SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-053539
Filing Date
2018-10-02
Accepted
2018-10-02 21:41:14
Documents
1
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 16545
  Complete submission text file 0001209191-18-053539.txt   19673
Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address
POWELL MICHAEL (Reporting) CIK: 0001202793 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103626

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address
HEALY JAMES (Reporting) CIK: 0001245624 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103624

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address
Mehra Anand (Reporting) CIK: 0001590102 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103625

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Venture Partners IX, L.P. (Reporting) CIK: 0001612133 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103622

Mailing Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD, 4-250 MENLO PARK CA 94025 650-681-8420
Sofinnova Management IX, L.L.C. (Reporting) CIK: 0001612134 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103623

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences